Dr. Jan Berger, author and analytics, clinical and population health expert will help guide Medecision’s leadership team to a broad market position in digital health.
DALLAS, TX – August 5, 2020 – Medecision, an integrated health management company, announced today that Jan Berger, MD, MJ, will serve as its new Advisory Board chair, succeeding Richard Popiel, MD, MBA, who served as Medecision’s founding Advisory Board Chair. Dr. Popiel remains a member of the Advisory Board following the completion of his term as Chairman. During his tenure, Dr. Popiel provided critical guidance on the formation of the Advisory Board and was instrumental in recruiting new members.
Dr. Popiel provided key guidance to Medecision’s leadership team on a wide variety of strategic and operational issues, particularly as we navigated the impact of the COVID-19 pandemic on our industry and business sector. We’re grateful for his insight, guidance and contributions, and look forward to his ongoing work with our Advisory Board and leadership.
Dr. Berger is an accomplished clinician, thought leader and advisor to many organizations in healthcare. She serves on public and private boards of directors and is a sought-after consultant with more than three decades of experience in the healthcare industry. Dr. Berger brings an extensive understanding of clinical policy and practice, population health strategies and has deep operational expertise in the health system, health plan and healthcare IT sectors. She is also a published author and sought-after speaker on behavioral health, healthcare IT and consumer health behavior.
Dr. Berger has made significant contributions to Medecision’s strategy and growth as a valued member of our Advisory Board over the past year, and we’re excited to have her leadership as our new Chair. Her advice and perspectives will help guide the company’s strategy and execution, particularly in the rapidly emerging market for virtual and digital health care solutions.
Now more than ever, our customers and prospects understand the critical nature of replacing disconnected point solutions and internal transactional systems with the comprehensive capabilities available with our Aerial™ platform. This platform powers data management, analytics, workflow and social-mobile engagement in a connected, consolidated and virtual experience for individuals, patients and members, and their care managers.
Dr. Berger is CEO of consulting group Health Intelligence Partners and has previously served as Chief Medical Officer and Chief Innovation Officer at CVS Health. Dr. Berger is also a member of the boards of Cambia Health Solutions, GNS Healthcare, Tabula Rasa Health Care (NASDAQ:TRHC), UCB (OTCMKTS:UCBJF) and Voluntis (EPA:VTX).
At Medecision, we believe in a liberated healthcare system where people, plans and care teams engage in driving the best health outcomes in a seamless, interconnected way. That’s why we invest every year in delivering a better Aerial™ Experience to our customers and the people they serve. See how the Aerial Experience enables better health and care for people like Joan, Mack and Margaret, who want to thrive while managing chronic conditions. With more than 30 years of business success under our belt, and nearly 50 million lives under Aerial management, we know what it takes to power success for our clients – more than 70 of the leading health plans and systems in the US. With our professional services division, Aveus, we tackle complex challenges in our pursuit to drive the best consumer experience. Learn more about our mission, vision, team and achievements by visiting medecision.com, or follow us on LinkedIn.